Vitrolife Ab · OMXSTO:VITR
Vitrolife Ab — Q4 2021 Earnings Presentation
9 slides from Vitrolife Ab's earnings presentation, Feb 16, 2022
Slide 1: Vitrolife AB (publ) Report on Operations 2021
VITROLIFE AB (PUBL) Report on Operations 2021 2022-02-16 Thomas Axelsson, CEO Patrik Tolf, CFO 1
Slide 2: Continuous Growth and a New Vitrolife
CONTINUOUS GROWTH AND A NEW VITROLIFE Q4: Jan-Dec: After the end of the period: • Sales of 514 MSEK (382) equals +35% in SEK • Sales of 1,681 MSEK (1,246) equals +35% • As of January 2022, we have a new • Sales increased by 34% in local currency in SEK management team and structure in place, • Sales
Slide 3: Sales and Growth per Market Region
SALES AND GROWTH PER MARKET REGION Q4 growth rate 95% 30% 14% -1% compared to last year in local currencies Whereof Organic growth 15% 5% 4% -13% Share of Vitrolife’s sales, 21% 44% 21% 15% rolling 12-months Sales (MSEK), rolling 12-months 354 735 347 245 3
Slide 4: Sales and Growth per Division
SALES AND GROWTH PER DIVISION SEK millions, rolling 12m Q4 growth rate 1800 compared to last year, local currency 1600 114 Genetic services 1400 136 129 142 153 Genomics +33% 116 102 1200 109 107 506 438 488 474 Technology -12% 1000 446 397 391 363 800 600 400 835 871 893 913 Consumables +9% 746 750
Slide 5: Key Financials Q4/FY
KEY FINANCIALS Q4/FY 2021 2020 2021 2020 Q4 Q4 FY FY • Sales growth: Sales, MSEK 514 382 1,681 1,246 – Q4 Sales growth 35%, whereof 30% acquired growth – FY sales growth 35%, whereof 9% acquired growth Gross Margin % 58% 66% 62% 62% • Adjusted Gross Margin – Q4 60%, impact from Genetic Services Adj.
Slide 6: Three Business Areas from 2022
THREE BUSINESS AREAS FROM 2022 Consumables incl. Genomics Technologies Genetic Services Develop and produce media, disposable Develop and produce equipment such as Reproductive genetic testing services. instruments and disposable plastic products. time-lapse and laser systems. Genomics offers kits f
Slide 7: Long-Term Outlook
LONG-TERM OUTLOOK Broadening the product and service offering Long-term market growth 5-10% in monetary Expansion of terms sales 7
Slide 8: Contact
Contact: Thomas Axelsson, CEO, taxelsson@vitrolife.com, +46 31 721 80 01 Patrik Tolf, CFO, ptolf@vitrolife.com, +46 31 766 90 21
Slide 9: Disclaimer
DISCLAIMER This presentation contains estimates and forward-looking statements, which reflect the Management’s current views with respect to the market, certain future events and financial performance. Although the statements are based upon estimates the Management believes to be reasonable, there i